A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice

Pharmacological Reports

Volumn 66, Issue 4, 2014, Pages 638-646

  Kruk Słomka, Marta ^a   Michalak, Agnieszka ^a   Budzyńska, Barbara ^a   Biała, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Bupropion; Mecamylamine; Nicotine; Novel object recognition test; Scopolamine

Indexed keywords

AMFEBUTAMONE; MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; NICOTINE; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; MEMORY; MEMORY DISORDER; MENTAL PERFORMANCE; MOUSE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; EXPLORATORY BEHAVIOR; PATTERN RECOGNITION;

ANALYSIS OF VARIANCE; ANIMALS; BUPROPION; CHOLINERGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MECAMYLAMINE; MEMORY; MICE; NICOTINE; PATTERN RECOGNITION, VISUAL; SCOPOLAMINE HYDROBROMIDE;

EID: 84902438726     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2014.02.002     Document Type: Article

References (68)

1. R. Agrawal, E. Tyagi, G. Saxena, and C. Nath Cholinergic influence on memory stages: a study on scopolamine amnesic mice Ind J Pharmacol 41 2009 192 196
2. M. Antunes, and G. Biala The novel object recognition memory: neurobiology, test procedure, and its modifications Cogn Process 13 2012 93 110
3. I. Bacher, B. Wu, D.R. Shytle, and T.P. George Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders Expert Opin Pharmacother 10 2009 2709 2721
4. C. Bejar, R.H. Wang, and M. Weinstock Effect of rivastigmine on scopolamine-induced memory impairment in rats Eur J Pharmacol 383 1999 231 240
5. V. Bertaina-Anglade, E. Enjuanes, D. Morillon, and C. Drieu la Rochelle The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity J Pharmacol Toxicol Methods 54 2006 99 105 (Pubitemid 44308867)
6. G. Biala, and M. Kruk Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze Pharmacol Rep 61 2009 236 244
7. G. Biala, and N. Staniak Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice Pharmacol Biochem Behav 96 2010 141 147
8. G. Biala, N. Staniak, and B. Budzynska Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats Naunyn-Schmiedeberg's Archiv Pharmacol 381 2010 361 370
9. M.G. Blake, M.M. Boccia, M.C. Krawczyk, and C.M. Baratti Scopolamine prevents retrograde memory interference between two different learning tasks Physiol Behav 102 2011 332 337
10. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 1993 31 39 (Pubitemid 23020772)
11. A. Blokland Acetylcholine a neurotransmitter for learning and memory? Brain Res Brain Rev 21 1995 285 300
12. R.W. Brown, K.S. Beale, and J. Frye Mecamylamine blocks enhancement of reference memory but not working memory produced by post-training injection of nicotine in rats tested on the radial arm maze Behav Brain Res 134 2002 259 265 (Pubitemid 34912705)
13. J.J. Buccafusco Neuronal nicotinic receptor subtypes: defining therapeutic targets Mol Interv 4 2004 285 295 (Pubitemid 39429936)
14. J.J. Buccafusco The revival of scopolamine reversal for the assessment of cognition-enhancing drugs J.J. Buccafusco, Methods of behavior analysis in neuroscience 2nd ed. 2009 CRC Press Boca Raton 329 341
15. N. Canal, and B.P. Imbimbo Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease Clin Pharmacol Ther 60 1996 218 228 (Pubitemid 26348237)
16. M.C. Carrasco, P. Vicens, J. Vidal, and R. Redolat Effects of acute administration of bupropion on behavior in the elevated plus maze test by NMRI mice Prog Neuropsychopharmacol Biol Psychiatry 28 2004 1135 1141 (Pubitemid 40017630)
17. J.F. Cryan, A.W. Bruijnzeel, K.L. Skjei, and A. Markou Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat Psychopharmacology 168 2003 347 358 (Pubitemid 36920920)
18. S. Deiana, B. Platt, and G. Riedel The cholinergic system and spatial learning Behav Brain Res 221 2011 389 411
19. J.C. Dodart, C. Mathis, and A. Ungerer Scopolamine-induced deficits in a two-trial object recognition task in mice NeuroReport 8 1997 1173 1178 (Pubitemid 27198592)
20. J. Dong, and P. Blier Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment Psychopharmacology 155 2001 52 57 (Pubitemid 32295769)
21. S.B. Dunnet, and L. Martel Proactive interference effects on short-term memory in rats. Basic parameters and drug effects Behav Neurosci 104 1990 655 665
22. U. Ebert, and W. Kirch Scopolamine model of dementia: electroencephalogram findings and cognitive performance Eur J Clin Invest 28 1998 944 949 (Pubitemid 28521587)
23. W.H. Frishman Smoking cessation pharmacotherapy Ther Adv Cardiovasc Dis 3 2009 287 308
24. S.D. Glick, and S. Greenstein Differential effects of scopolamine and mecamylamine on passive avoidance behavior Life Sci 11 1972 169 179
25. M.E. Hasselmo The role of acetylcholine in learning and memory Curr Opin Neurobiol 16 2006 710 715 (Pubitemid 44791918)
26. J.T. Hays, and J.O. Ebbert Bupropion for the treatment of tobacco dependence. Guidelines for balancing risks and benfits CNS Drugs 17 2003 71 83 (Pubitemid 36194307)
27. M. Hiramatsu, and K. Inoue Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory Eur J Pharmacol 395 2000 149 156 (Pubitemid 30224819)
28. P.-H. Hsyu, A. Singh, T.D. Giargiari, J.A. Dunn, J.A. Ascher, and J.A. Johnston Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers J Clin Pharmacol 37 1997 737 743 (Pubitemid 27449283)
29. K. Ichihara, T. Nabeshima, and T. Kameyama Effects of dopamine receptor antagonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors Eur J Pharmacol 213 1992 243 249
30. M. Karam-Hage, and P.M. Cinciripini Pharmacotherapy for tobacco cessation: nicotine agonists, antagonists, and partial agonists Curr Oncol Rep 9 2007 509 516 (Pubitemid 350081488)
31. Y.H. Kim, Y. Lee, D. Kim, M.W. Jung, and C.J. Lee Scopolamine-induced learning impairment reversed by physostigmine in zebrafish Neurosci Res 67 2010 156 161
32. D. Knopman Pharmacotherapy for Alzheimer's disease Curr Neurol Neurosci 1 2001 428 434
33. M. Kruk, K. Tendera, and G. Biała Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test Pharmacol Rep 63 2011 1372 1382
34. E.D. Levin, and A.H. Rezvani Development of nicotinic drug therapy for cognitive disorders Eur J Pharmacol 393 2000 141 146 (Pubitemid 30193410)
35. E.D. Levin, and A.H. Rezvani Nicotinic treatment for cognitive dysfunction Curr Drug Target CNS Neurol Disord 1 2002 423 431
36. E.D. Levin, and A.H. Rezvani Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function Biochem Pharmacol 74 2007 1182 1191 (Pubitemid 47417933)
37. E.D. Levin, and B. Simon Nicotinic acetylcholine involvement in cognitive function in animals Psychopharmacology 138 1998 217 230 (Pubitemid 28365487)
38. E.D. Levin, S. Kaplan, and A. Boardman Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze Behav Pharmacol 8 1997 236 242 (Pubitemid 27303918)
39. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology 184 2006 523 539 (Pubitemid 43255869)
40. E.D. Levin, A. Petro, A.H. Rezvani, N. Pollard, N.C. Christopher, and M. Strauss et al. Nicotinic α7- or β2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice Behav Brain Res 196 2009 207 213
41. P. Martin, J. Massol, J.N. Colin, L. Lacomblez, and A.J. Puech Antidepressant profile of bupropion and three metabolites in mice Pharmacopsychiatry 23 1990 187 194 (Pubitemid 20311507)
42. T. Masuoka, and C. Kamei The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits Psychopharmacology 206 2009 259 265
43. D.K. Miller, S.P. Sumithran, and L.P. Dwoskin Bupropion inhibits nicotine-evoked [3H] overflow from rat striatal slices preloaded with [3H] dopamine and from rat hippocampal slices preloaded with [3H] norepinephrine J Pharmacol Exp Ther 302 2002 1113 1122 (Pubitemid 34920233)
44. N.R. Mirza, and I.P. Stolerman The role of nicotinic and muscarinic acetylcholine receptors in attention Psychopharmacology 48 2000 243 250 (Pubitemid 30136731)
45. S. Miyazaki, M. Imaizumi, and K. Onodera Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice Life Sci 56 1995 1563 1570
46. P.M. Moran Scopolamine deficits in negative patterning discrimination: evidence for a role of the central cholinergic system in retention but not acquisition of non-spatial configural association learning Behav Brain Res 48 1992 187 197
47. R.S. Naik, J. Hartmann, C. Kiewert, E.G. Duysen, O. Lockridge, and J. Klein Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice J Pharm Pharm Sci 12 2009 79 85
48. E.J. Nestler Neurobiology. Total recall-the memory of addiction Science 292 2001 2266 2267 (Pubitemid 32568035)
49. E.J. Nestler Common molecular and cellular substrates of addiction and memory Neurobiol Learn Mem 78 2002 637 647 (Pubitemid 36268684)
50. R.L. Papke, P.R. Sanberg, and R.D. Shytle Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes J Pharmacol Exp Ther 297 2001 646 656 (Pubitemid 32377996)
51. A.H. Rezvani, and E.D. Levin Cognitive effects of nicotine Biol Psychiatry 49 2001 258 267 (Pubitemid 32178435)
52. J.O. Rinne, T. Myllykyla, P. Lonnberg, and P. Marjamaki A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease Brain Res 547 1991 167 170
53. A. Sambeth, W.J. Riedel, L.T. Smits, and A. Blokland Cholinergic drugs affect novel object recognition in rats: relation with hippocampal EEG Eur J Pharmacol 572 2007 151 159 (Pubitemid 47429642)
54. D. Sanders, D. Simkiss, D. Braddy, S. Baccus, T. Morton, and R. Cannady et al. Nicotinic receptors in the habenula: importance for memory Neuroscience 166 2010 386 390
55. K. Schon, A. Atri, M.E. Hasselmo, M.D. Tricarico, M.L. LoPresti, and C.E. Stern Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans J Neurosci 25 2005 9112 9123 (Pubitemid 41500819)
56. S. Shiffman, J.A. Johnston, M. Khayrallah, C.A. Elash, C.J. Gwaltney, and J.A. Paty et al. The effect of bupropion on nicotine craving and withdrawal Psychopharmacology 148 2000 33 40 (Pubitemid 30062470)
57. S. Shimohama, T. Taniguchi, M. Fujiwara, and M. Kameyama Changes in nicotinic and muscarinic receptors in Alzheimer-type dementia J Neurochem 46 1986 288 293 (Pubitemid 16185459)
58. J.E. Slemmer, B.R. Martin, and M.I. Damaj Bupropion is a nicotinic antagonist J Pharmacol Exp Ther 295 2000 321 327
59. E.P. Sloan, G.W. Fenton, and K.P. Standage Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory Biol Psychiatry 31 1992 600 606
60. S.R. Tella, B. Ladenheim, and J.L. Cadet Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine J Pharmacol Exp Ther 281 1997 508 513 (Pubitemid 27203109)
61. E. Trofimiuk, A. Walesiuk, and J.J. Braszko St John's wort (Hypericum perforatum) diminishes cognitive impairment caused by the chronic restraint stress in rats Pharmacol Res 51 2005 239 246 (Pubitemid 40127216)
62. B.D. Winters, L.M. Saksida, and T.J. Bussey Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval Neurosci Biobehav Rev 32 2008 1055 1070
63. S. Wonnacott Presynaptic nicotinic ACh receptors Trends Neurosci 20 1997 92 98 (Pubitemid 27050704)
64. D.S. Woodruff-Pak Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning Behav Brain Res 143 2003 159 167 (Pubitemid 36937161)
65. R. Yin, and E.D. French A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study Brain Res Bull 51 2000 507 514 (Pubitemid 30176095)
66. J. Yu, Y.W. Huang, and Z. Chen Improved alternative electro-stimulus Y-maze for evaluating the spatial memory of rats J Zhejiang Univ Sci 32 2003 121 125
67. M.R. Zarrindast, and A. Minaian Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice Gen Pharmacol 22 1991 1017 1021
68. M.R. Zarrindast, M.R. Hodjati, A. Pejhan, and E. Soleimannejad Bupropion induces sniffing: a possible dopaminergic mechanism Eur Neuropsychopharmacol 6 1996 299 303 (Pubitemid 26422790)